chr8-91070346-A-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The ENST00000285420.8(OTUD6B):āc.52A>Gā(p.Arg18Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,613,194 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000285420.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTUD6B | NM_016023.5 | c.-39A>G | 5_prime_UTR_variant | 1/7 | ENST00000404789.8 | NP_057107.4 | ||
OTUD6B | NM_001416022.1 | c.-39A>G | 5_prime_UTR_variant | 1/6 | NP_001402951.1 | |||
OTUD6B | NM_001286745.3 | c.-482A>G | 5_prime_UTR_variant | 1/8 | NP_001273674.1 | |||
OTUD6B | XM_047421864.1 | c.-39A>G | 5_prime_UTR_variant | 1/4 | XP_047277820.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTUD6B | ENST00000404789 | c.-39A>G | 5_prime_UTR_variant | 1/7 | 1 | NM_016023.5 | ENSP00000384190.4 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000366 AC: 91AN: 248344Hom.: 0 AF XY: 0.000268 AC XY: 36AN XY: 134368
GnomAD4 exome AF: 0.000117 AC: 171AN: 1460896Hom.: 2 Cov.: 31 AF XY: 0.0000991 AC XY: 72AN XY: 726624
GnomAD4 genome AF: 0.00108 AC: 164AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.00103 AC XY: 77AN XY: 74476
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 12, 2019 | Variant summary: OTUD6B c.52A>G (p.Arg18Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 in 248344 control chromosomes, predominantly at a frequency of 0.0046 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 4-fold of the estimated maximal expected allele frequency for a pathogenic variant in OTUD6B causing Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies phenotype (0.0011), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.52A>G in individuals affected with Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 11, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
OTUD6B-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 31, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at